A predictive model for the development of chronic obstructive pulmonary disease

Guo,Yi; Qian,Yanrong; Gong,Yi; Pan,Chunming; Shi,Guochao; Wan,Huanying

doi:10.3892/br.2015.503

A predictive model for the development of chronic obstructive pulmonary disease

Authors:
- Yi Guo
- Yanrong Qian
- Yi Gong
- Chunming Pan
- Guochao Shi
- Huanying Wan
View Affiliations

Affiliations: Department of Pulmonary Medicine, Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200025, P.R. China, Department of Pulmonary Medicine, Huashan Hospital, Fudan University, Shanghai 200040, P.R. China, State Key Laboratory of Medical Genomics, Molecular Medicine Center, Shanghai Ruijin Hospital, Shanghai 200025, P.R. China
Published online on: August 5, 2015 https://doi.org/10.3892/br.2015.503
Pages: 853-863

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The screening of a person at risk for chronic obstructive pulmonary disease (COPD) and timely treatment may provide opportunities to delay the progressive destruction of lung function. Therefore, a model to predict the disease is required. We hypothesized that demographic and clinical information in combination with genetic markers would aid in the prediction of COPD development, prior to its onset. The aim of the present study was to create a predictive model for COPD development. Demographic, clinical presentation and genetic polymorphisms were recorded in COPD patients and control subjects. Nighty‑six single‑nucleotide polymorphisms of 46 genes were selected for genotyping in the case‑control study. A predictive model was produced using logistic regression with a stepwise model‑building approach and was validated. A total of 331 patients and 351 control subjects were included. The logistic regression identified the following predictors: Gender, respiratory infection in early life, low birth weight, smoking history and genotype polymorphisms (rs2070600, rs10947233, rs1800629, rs2241712 and rs1205). The model was established using the following formula: COPD = 1/[1 + exp (‑2.4933‑1.2197 gender + 1.1842 respiratory infection in early life + 2.4350 low birth weight + 1.8524 smoking ‑ 1.1978 rs2070600 + 2.0270 rs10947233 + 1.1913 rs10947233 + 0.6468 rs1800629 + 0.5272 rs2241712 + 0.4024 rs1205)] (when the value is >0.5). The Hosmer‑Lemeshow test showed no significant deviations between the observed and predicted events. Validation of the model in 50 patients showed a modest sensitivity and specificity. Therefore, a predictive model based on demographic, clinical and genetic information may identify COPD prior to its onset.

View Figures

View References

1	Rabe KF, Beghé B, Luppi F and Fabbri LM: Update in chronic obstructive pulmonary disease 2006. Am J Respir Crit Care Med. 175:1222–1232. 2007. View Article : Google Scholar : PubMed/NCBI
2	Murray CJL and Lopez AD: Evidence-based health policy - lessons from the Global Burden of Disease Study. Science. 274:740–743. 1996. View Article : Google Scholar : PubMed/NCBI
3	Celli BR, MacNee W, Agusti A, et al: ATS/ERS Task Force: Standards for the diagnosis and treatment of patients with COPD: A summary of the ATS/ERS position paper. Eur Respir J. 23:932–946. 2004. View Article : Google Scholar : PubMed/NCBI
4	Wang X, Li L, Xiao J, Jin C, Huang K, Kang X, Wu X and Lv F: Association of ADAM33 gene polymorphisms with COPD in a northeastern Chinese population. BMC Med Genet. 10:132–138. 2009. View Article : Google Scholar : PubMed/NCBI
5	Zhong N, Wang C, Yao W, et al: Prevalence of chronic obstructive pulmonary disease in China: A large, population-based survey. Am J Respir Crit Care Med. 176:753–760. 2007. View Article : Google Scholar : PubMed/NCBI
6	Nihlén U, Montnémery P, Lindholm LH and Löfdahl CG: Detection of chronic obstructive pulmonary disease (COPD) in primary health care: Role of spirometry and respiratory symptoms. Scand J Prim Health Care. 17:232–237. 1999. View Article : Google Scholar : PubMed/NCBI
7	Lindberg A, Bjerg A, Rönmark E, Larsson LG and Lundbäck B: Prevalence and underdiagnosis of COPD by disease severity and the attributable fraction of smoking Report from the Obstructive Lung Disease in Northern Sweden Studies. Respir Med. 100:264–272. 2006. View Article : Google Scholar : PubMed/NCBI
8	Tinkelman DG, Price D, Nordyke RJ and Halbert RJ: COPD screening efforts in primary care: What is the yield? Prim Care Respir J. 16:41–48. 2007. View Article : Google Scholar : PubMed/NCBI
9	Miravitlles M, Soriano JB, García-Río F, Muñoz L, Duran-Tauleria E, Sanchez G, Sobradillo V and Ancochea J: Prevalence of COPD in Spain: Impact of undiagnosed COPD on quality of life and daily life activities. Thorax. 64:863–868. 2009. View Article : Google Scholar : PubMed/NCBI
10	Shahab L, Jarvis MJ, Britton J and West R: Prevalence, diagnosis and relation to tobacco dependence of chronic obstructive pulmonary disease in a nationally representative population sample. Thorax. 61:1043–1047. 2006. View Article : Google Scholar : PubMed/NCBI
11	Calverley PM: COPD: Early detection and intervention. Chest. 117 (Suppl 2):365S–371S. 2000. View Article : Google Scholar : PubMed/NCBI
12	Hersh CP, DeMeo DL, Al-Ansari E, et al: Predictors of survival in severe, early onset COPD. Chest. 126:1443–1451. 2004. View Article : Google Scholar : PubMed/NCBI
13	Nizet TA, van den Elshout FJ, Heijdra YF, et al: Survival of chronic hypercapnic COPD patients is predicted by smoking habits, comorbidity, and hypoxemia. Chest. 127:1904–1910. 2005. View Article : Google Scholar : PubMed/NCBI
14	Silverman EK: Progress in chronic obstructive pulmonary disease genetics. Proc Am Thorac Soc. 3:405–408. 2006. View Article : Google Scholar : PubMed/NCBI
15	Løkke A, Lange P, Scharling H, Fabricius P and Vestbo J: Developing COPD: A 25 year follow up study of the general population. Thorax. 61:935–939. 2006. View Article : Google Scholar : PubMed/NCBI
16	Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, Koskenvuo M, Pukkala E, Skytthe A and Hemminki K: Environmental and heritable factors in the causation of cancer - analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med. 343:78–85. 2000. View Article : Google Scholar : PubMed/NCBI
17	McCloskey SC, Patel BD, Hinchliffe SJ, Reid ED, Wareham NJ and Lomas DA: Siblings of patients with severe chronic obstructive pulmonary disease have a significant risk of airflow obstruction. Am J Respir Crit Care Med. 164:1419–1424. 2001. View Article : Google Scholar : PubMed/NCBI
18	Wilk JB, Chen TH, Gottlieb DJ, et al: A genome-wide association study of pulmonary function measures in the Framingham Heart Study. PLoS Genet. 5:e10004292009. View Article : Google Scholar : PubMed/NCBI
19	Pillai SG, Ge D, Zhu G, et al: ICGN Investigators: A genome-wide association study in chronic obstructive pulmonary disease (COPD): Identification of two major susceptibility loci. PLoS Genet. 5:e10004212009. View Article : Google Scholar : PubMed/NCBI
20	Rabe KF, Hurd S, Anzueto A, et al: Global Initiative for Chronic Obstructive Lung Disease: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 176:532–555. 2007. View Article : Google Scholar : PubMed/NCBI
21	Gong Y, Shi GC, Wan HY, et al: Reinvestigation of prevalence of chronic obstructive pulmonary disease in shanghai urban district. J Shanghai Jiaotong Univ (Med Sci). 31:100–104. 2011.
22	Stratelis G, Jakobsson P, Molstad S and Zetterstrom O: Early detection of COPD in primary care: Screening by invitation of smokers aged 40 to 55 years. Br J Gen Pract. 54:201–206. 2004.PubMed/NCBI
23	Stratelis G, Mölstad S, Jakobsson P and Zetterström O: The impact of repeated spirometry and smoking cessation advice on smokers with mild COPD. Scand J Prim Health Care. 24:133–139. 2006. View Article : Google Scholar : PubMed/NCBI
24	Grouse L: New studies address urgent need for early COPD diagnosis. J Thorac Dis. 4:19–21. 2012.PubMed/NCBI
25	LeyZaporozhan J and Kauczor HU: Imaging of airways: Chronic obstructive pulmonary disease. Radiol Clin North Am. 47:331–342. 2009. View Article : Google Scholar : PubMed/NCBI
26	Fain SB, Panth SR, Evans MD, Wentland AL, Holmes JH, Korosec FR, O'Brien MJ, Fountaine H and Grist TM: Early emphysematous changes in asymptomatic smokers: Detection with ³He MR imaging. Radiology. 239:875–883. 2006. View Article : Google Scholar : PubMed/NCBI
27	Schembri S, Anderson W, Morant S, Winter J, Thompson P, Pettitt D, MacDonald TM and Winter JH: A predictive model of hospitalisation and death from chronic obstructive pulmonary disease. Respir Med. 103:1461–1467. 2009. View Article : Google Scholar : PubMed/NCBI
28	Castaldi PJ, DeMeo DL, Kent DM, et al: Development of predictive models for airflow obstruction in alpha-1-antitrypsin deficiency. Am J Epidemiol. 170:1005–1013. 2009. View Article : Google Scholar : PubMed/NCBI
29	Lode H, Allewelt M, Balk S, De Roux A, Mauch H, Niederman M and Schmidt-Ioanas M: A prediction model for bacterial etiology in acute exacerbations of COPD. Infection. 35:143–149. 2007. View Article : Google Scholar : PubMed/NCBI
30	Villavicencio EH, Walterhouse DO and Iannaccone PM: The sonic hedgehog-patched-gli pathway in human development and disease. Am J Hum Genet. 67:1047–1054. 2000. View Article : Google Scholar : PubMed/NCBI
31	Sakao S, Tatsumi K, Igari H, Watanabe R, Shino Y, Shirasawa H and Kuriyama T: Association of tumor necrosis factor-alpha gene promoter polymorphism with low attenuation areas on high-resolution CT in patients with COPD. Chest. 122:416–420. 2002. View Article : Google Scholar : PubMed/NCBI
32	Keicho N, Emi M, Nakata K, Taguchi Y, Azuma A, Tokunaga K, Ohishi N and Kudoh S: Promoter variation of tumour necrosis factor-alpha gene: Possible high risk for chronic bronchitis but not diffuse panbronchiolitis. Respir Med. 93:752–753. 1999. View Article : Google Scholar : PubMed/NCBI
33	Stankovic MM, Nestorovic AR, Tomovic AM, Petrovic Stanojevic ND, Andjelic Jelic MS, Dopudja Pantic VB, Nagorni Obradovic LJM, Mitic Milikic MM and Radojkovic DP: TNF-alpha-308 promotor polymorphism in patients with chronic obstructive pulmonary disease and lung cancer. Neoplasma. 56:348–352. 2009. View Article : Google Scholar : PubMed/NCBI
34	Papatheodorou A, Latsi P, Vrettou C, et al: Development of a novel microarray methodology for the study of SNPs in the promoter region of the TNF-alpha gene: Their association with obstructive pulmonary disease in Greek patients. Clin Biochem. 40:843–850. 2007. View Article : Google Scholar : PubMed/NCBI
35	Su ZG, Wen FQ, Feng YL, Xiao M and Wu XL: Transforming growth factor-beta 1 gene polymorphisms associated with chronic obstructive pulmonary disease in Chinese population. Acta Pharmacol Sin. 26:714–720. 2005. View Article : Google Scholar : PubMed/NCBI
36	Beghé B, Hall IP, Parker SG, Moffatt MF, Wardlaw A, Connolly MJ, Fabbri LM, Ruse C and Sayers I: Polymorphisms in IL13 pathway genes in asthma and chronic obstructive pulmonary disease. Allergy. 65:474–481. 2010. View Article : Google Scholar : PubMed/NCBI
37	Sunyer J, Pistelli R, Plana E, Andreani M, Baldari F, Kolz M, Koenig W, Pekkanen J, Peters A and Forastiere F: Systemic inflammation, genetic susceptibility and lung function. Eur Respir J. 32:92–97. 2008. View Article : Google Scholar : PubMed/NCBI